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Supplemental Figure 1. Partial amino acid sequence alignment of actinobacterial and mammalian 
cytochrome P450 proteins: R. jostii RHA1 CYP125 (accession number ABG96465), R. 
rhodochrous DSM43269 CYP125 (FJ824698), M. tuberculosis H37Rv CYP125 (NP_218062), 
bovine CYP11A1 (NP_788817), human CYP27A1 (NP_000775), human CYP3A4 (P08684) and 
human CYP46A1 (NP_006659). The alignment was generated using ClustalW, MEGA version 
3.1 (Kumar et al., 2004). Specific residues discussed in the text in bold are indicated (V295, 
R300 and R343 of Cyp125RHA1). Structure homology modeling of the CYP11A1:cholesterol 
complex revealed that the conserved arginine (R357, corresponding to R300 of CYP125RHA1) 
points towards the docked cholesterol and is believed to be involved in catalysis (Storbeck et al., 
2007). Moreover, this residue was shown to be one of the active site residues in CYP46A1 (Mast 
et al., 2008) and has been recently identified in P450s (e.g. CYP3A4) as a heme-interacting 
residue involved in substrate regio-selectivity and specificity (Seifert and Pleiss, 2009). For its 
part, the conserved arginine of CYP27A1 (R415, corresponding to R343 of CYP125RHA1) was 
shown to be connected via a tripartite salt-bridge with the ExxR motif, forming an ERR-triad as 
part of the active site cavity (Prosser et al., 2006; Masuda et al., 2007). Finally, in CYP27A1, 
V367 (corresponding to V295 of CYP125RHA1) is an active site residue and appears to be crucial 
for regioselectivity of hydroxylation of both cholesterol and 5β-cholestane 3α,7α,12α-triol (Mast 
et al., 2006). Conserved motifs of the P450s super-family (ExxR
 
and PxxF), the oxygen-binding 
domain (GxxT) and the heme binding domain (F[x]xxGxxxCxG) (Mestres, 2005; Huang et al., 2008) 




                      GxxT    
CYP125_RHA1  235 LSPEEFGFFVILLAVAGNETTRNAITHGMMAFLDHPD 
CYP125_DSM43269  235 LAPEEFGFFFIVLAVAGNETTRNAITHGMAAFLDNPE 
CYP125_H37Rv  253 LSDDEFGFFVVMLAVAGNETTRNSITQGMMAFAEHPD 
CYP11A1  272 MLLEDVKANITEMLAGGVNTTSMTLQWHLYEMARSLN 
CYP27A1h  287 LSPREAMGSLPELLMAGVDTTSNTLTWALYHLSKDPE 
CYP3A4h  290 LSDLELVAQSIIFIFAGYETTSSVLSFIMYELATHPD 
CYP46A1h  287 QDDEGLLDNFVTFFIAGHETSANHLAFTVMELSRQPE 
 
 
           ExxR    V295 R300                                PxxF  R343        
CYP125_RHA1   282 KTTADEIVRWATPVNSFQRTALEDTELGGVQIKKGQRVVMLYGSANFDEDAFENPEKFDIMR 
CYP125_DSM43269  282 KTAADEIIRWATPVTSFQRTALEDTELGGQTIRKGERVVMLYASANNDEEVFENPREFDILR 
CYP125_H37Rv  300 ETAADEIVRWATPVTAFQRTALRDYELSGVQIKKGQRVVMFYRSANFDEEVFQDPFTFNILR 
CYP11A1  339 KASIKETLRLHPISVTLQRYPESDLVLQDYLIPAKTLVQVAIYAMGRDPAFFSSPDKFDPTR 
CYP27A1h  354 KAVLKETLRLYPVVPTNSRIIEKEIEVDGFLFPKNTQFVFCHYVVSRDPTAFSEPESFQPHR 
CYP3A4h  357 DMVVNETLRLFPIAMRLERVCKKDVEINGMFIPKGVVVMIPSYALHRDPKYWTEPEKFLPER 
CYP46A1h  354 SQVLKESLRLYPPAWGTFRLLEEETLIDGVRVPGNTPLLFSTYVMGRMDTYFEDPLTFNPDR 
 
  
        FxxxGxxxCxG 
CYP125_RHA1  349 VGFGGTGAHFCLGANLARLEIDL 
CYP125_DSM43269  349 LAFGGTGAHYCLGANLARMEIDL 
CYP125_H37Rv  367 VGFGGTGAHYCIGANLARMTINL 
CYP11A1  414 LGF-GWGVRQCVGRRIAELEMTL 
CYP27A1h  434 VPF-GYGVRACLGRRIAELEMQL 
CYP3A4h  433 TPF-GSGPRNCIGMRFALMNMKL 
CYP46A1h  428 FPF-SLGHRSCIGQQFAQMEVKV 
  




























1. NaH, CS2, MeI, imidazole















Supplemental Figure 3. (A) MS spectrum with fragmentation pattern of chemically synthesized 5-
cholestene-26-oic acid-3β-ol. (B) MS-MS spectrum with fragmentation pattern of ion peak with m/z 399. 
 






































Supplemental Table 1. Growth of wild type Rhodococcus jostii strain RHA1 and mutant strain 
RHA1∆cyp125 on different sterols and related organic substrates. Growth is indicated with (+), whereas 
no growth is indicated with (-). 
 
































































































































































* Mixture of β-sitosterol (>75 %) with β-sitostanol (10-14 %) and campesterol (6-9 %) was used. 
 
 






Rhodococcus  jostii RHA1 Wild type strain, PCB degrader (Masai et al., 1995) 
Rhodococcus rhodochrous 
DSM43269 






Mutant strain of DSM43269 capable of selective sterol side 
chain degradation; carries 5-fold unmarked kshA gene 
deletion 
Wilbrink et al., 
unpublished  
 
E. coli DH5α General host for cloning Bethesda Res. 
Laboratories 
E. coli S17-1 
 
Host strain for conjugal mobilization of pK18mobsacB 










cyp125 gene disruption mutant strain of RG32; blocked 







Conjugative plasmid for gene mutagenesis in 
Rhodococcus; aphII sacB oriT (RP4) lacZ 
(Van der Geize et 
al., 2001) 
pBlueScript KS(II) General E. coli cloning vector; bla lacZ Stratagene 
pTip-QC1 
 






E.coli-Rhodococcus shuttle-vector; aphII, lacZ-ccdB rep 
(pMVS301)  




Conjugative pBlueScript KS(II) derivative; aacIV, oriT 
(RP4) lacZ   
(Van der Geize et 
al., 2008) 
pRRE1 E. coli- R. rhodochrous shuttle-vector This study 
pDELcyp125RHA1 
 
pK18mobsacB-derived mutagenic plasmid for cyp125RHA1 




cyp125RHA1 expression plasmid used for CYP125RHA1 
production and functional complementation of 
RHA1∆cyp125 
This study 
pRESQ4679 Genomic library clone DSM43269 carrying cyp125DSM43269  This study 
pΩcyp125 
 
pK18mobsacB derived mutagenic plasmid for cyp125 gene 




pRRE1-derived plasmid carrying cyp125DSM43269 ; 
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